Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Sustained Attentional States Require Distinct Temporal Involvement of the Dorsal and Ventral Medial Prefrontal Cortex.

Luchicchi A, Mnie-Filali O, Terra H, Bruinsma B, de Kloet SF, Obermayer J, Heistek TS, de Haan R, de Kock CP, Deisseroth K, Pattij T, Mansvelder HD.

Front Neural Circuits. 2016 Aug 31;10:70. doi: 10.3389/fncir.2016.00070. eCollection 2016.

2.

Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro.

Mnie-Filali O, Lau T, Matthaeus F, Abrial E, Delcourte S, El Mansari M, Pershon A, Schloss P, Sánchez C, Haddjeri N.

CNS Neurosci Ther. 2016 Aug;22(8):691-9. doi: 10.1111/cns.12562. Epub 2016 May 12.

PMID:
27171685
3.

Axonal Segregation and Role of the Vesicular Glutamate Transporter VGLUT3 in Serotonin Neurons.

Voisin AN, Mnie-Filali O, Giguère N, Fortin GM, Vigneault E, El Mestikawy S, Descarries L, Trudeau LÉ.

Front Neuroanat. 2016 Apr 12;10:39. doi: 10.3389/fnana.2016.00039. eCollection 2016.

4.

Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.

Charfi I, Nagi K, Mnie-Filali O, Thibault D, Balboni G, Schiller PW, Trudeau LE, Pineyro G.

Cell Mol Life Sci. 2014 Apr;71(8):1529-46.

5.

A neuroanatomical and neurochemical study of the indusium griseum and anterior hippocampal continuation: comparison with dentate gyrus.

Laplante F, Mnie-Filali O, Sullivan RM.

J Chem Neuroanat. 2013 May;50-51:39-47. doi: 10.1016/j.jchemneu.2013.03.004. Epub 2013 Apr 1.

PMID:
23557710
6.

Differential association of receptor-Gβγ complexes with β-arrestin2 determines recycling bias and potential for tolerance of δ opioid receptor agonists.

Audet N, Charfi I, Mnie-Filali O, Amraei M, Chabot-Doré AJ, Millecamps M, Stone LS, Pineyro G.

J Neurosci. 2012 Apr 4;32(14):4827-40. doi: 10.1523/JNEUROSCI.3734-11.2012.

7.

Synergistic antidepressant-like action of gaboxadol and escitalopram.

Christensen T, Bétry C, Mnie-Filali O, Etievant A, Ebert B, Haddjeri N, Wiborg O.

Eur Neuropsychopharmacol. 2012 Oct;22(10):751-60. doi: 10.1016/j.euroneuro.2012.02.001. Epub 2012 Mar 9.

PMID:
22406239
8.

Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy.

Mnie-Filali O, Faure C, Lambás-Señas L, El Mansari M, Belblidia H, Gondard E, Etiévant A, Scarna H, Didier A, Berod A, Blier P, Haddjeri N.

Neuropsychopharmacology. 2011 May;36(6):1275-88. doi: 10.1038/npp.2011.13. Epub 2011 Feb 16.

9.

Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.

Lucas G, Du J, Romeas T, Mnie-Filali O, Haddjeri N, Piñeyro G, Debonnel G.

PLoS One. 2010 Feb 16;5(2):e9253. doi: 10.1371/journal.pone.0009253.

10.

Serotonin 4 receptor (5-HT4R) internalization is isoform-specific: effects of 5-HT and RS67333 on isoforms A and B.

Mnie-Filali O, Amraei MG, Benmbarek S, Archer-Lahlou E, Peñas-Cazorla R, Vilaró MT, Boye SM, Piñeyro G.

Cell Signal. 2010 Mar;22(3):501-9. doi: 10.1016/j.cellsig.2009.11.004.

PMID:
19922792
11.

Therapeutic potential of 5-HT7 receptors in mood disorders.

Mnie-Filali O, Lambas-Señas L, Scarna H, Haddjeri N.

Curr Drug Targets. 2009 Nov;10(11):1109-17.

PMID:
19702552
12.

Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression.

Romeas T, Morissette MC, Mnie-Filali O, Piñeyro G, Boye SM.

Psychopharmacology (Berl). 2009 Aug;205(2):293-303. doi: 10.1007/s00213-009-1539-y. Epub 2009 Apr 29.

PMID:
19404615
13.

F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: influence on neuronal firing and neurotransmitter release.

Assié MB, Mnie-Filali O, Ravailhe V, Benas C, Marien M, Bétry C, Zimmer L, Haddjeri N, Newman-Tancredi A.

Eur J Pharmacol. 2009 Apr 1;607(1-3):74-83.

PMID:
19326477
14.

Functional correlates for 5-HT(1A) receptors in maternally deprived rats displaying anxiety and depression-like behaviors.

Lambás-Señas L, Mnie-Filali O, Certin V, Faure C, Lemoine L, Zimmer L, Haddjeri N.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):262-8. doi: 10.1016/j.pnpbp.2008.11.017. Epub 2008 Dec 7.

PMID:
19111592
15.

[Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].

Mnie-Filali O, El Mansari M, Scarna H, Zimmer L, Sánchez C, Haddjeri N.

Encephale. 2007 Dec;33(6):965-72. doi: 10.1016/j.encep.2007.11.001. Epub 2007 Dec 11. Review. French.

PMID:
18789789
16.

Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.

Dahan L, Husum H, Mnie-Filali O, Arnt J, Hertel P, Haddjeri N.

J Psychopharmacol. 2009 Mar;23(2):177-89. doi: 10.1177/0269881108089586. Epub 2008 May 30.

PMID:
18515444
17.

5-HT7 receptor antagonists as a new class of antidepressants.

Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N.

Drug News Perspect. 2007 Dec;20(10):613-8. doi: 10.1358/dnp.2007.20.10.1181354. Review.

PMID:
18301795
18.

R-citalopram prevents the neuronal adaptive changes induced by escitalopram.

Mnie-Filali O, Faure C, Mansari ME, Lambás-Señas L, Bérod A, Zimmer L, Sánchez C, Haddjeri N.

Neuroreport. 2007 Oct 8;18(15):1553-6.

PMID:
17885600
19.

Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.

Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, Lambas-Senas L, Wiborg O, Haddjeri N, Piñeyro G, Sadikot AF, Debonnel G.

Neuron. 2007 Sep 6;55(5):712-25.

20.

Effects of the serotonin 5-HT(7) receptor antagonist SB-269970 on the inhibition of dopamine neuronal firing induced by amphetamine.

Mnie-Filali O, Dahan L, Zimmer L, Haddjeri N.

Eur J Pharmacol. 2007 Sep 10;570(1-3):72-6. Epub 2007 Jun 5.

PMID:
17586491
21.

Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT.

Faure C, Mnie-Filali O, Scarna H, Debonnel G, Haddjeri N.

Neurosci Lett. 2006 Aug 14;404(1-2):122-6. Epub 2006 Jun 8.

PMID:
16759802
22.

Long-term adaptive changes induced by serotonergic antidepressant drugs.

Faure C, Mnie-Filali O, Haddjeri N.

Expert Rev Neurother. 2006 Feb;6(2):235-45. Review.

PMID:
16466303
23.

Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.

Mansari ME, Wiborg O, Mnie-Filali O, Benturquia N, Sánchez C, Haddjeri N.

Int J Neuropsychopharmacol. 2007 Feb;10(1):31-40. Epub 2006 Feb 1.

PMID:
16448580
24.

Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity.

Mnie-Filali O, El Mansari M, Espana A, Sànchez C, Haddjeri N.

Neurosci Lett. 2006 Feb 27;395(1):23-7. Epub 2005 Dec 5.

PMID:
16330146
25.

In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system.

Haddjeri N, Faure C, Lucas G, Mnie-Filali O, Chouvet G, Astier B, Renaud B, Blier P, Debonnel G.

Int J Neuropsychopharmacol. 2004 Dec;7(4):391-9. Epub 2004 May 12.

PMID:
15140278

Supplemental Content

Loading ...
Support Center